Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative-effect adjustment from adoption of ASU 2020-06	Restricted Stock Units	Common Stock	Common Stock Restricted Stock Units	Additional Paid-In Capital	Additional Paid-In Capital Cumulative-effect adjustment from adoption of ASU 2020-06	Additional Paid-In Capital Restricted Stock Units	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated Deficit Cumulative-effect adjustment from adoption of ASU 2020-06
Beginning balance (in shares) at Feb. 06, 2022				292,633
Beginning balance at Feb. 06, 2022	$ 754,336	$ (35,127)		$ 29		$ 2,470,943	$ (133,265)		$ (8,365)	$ (1,708,271)	$ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,988
Issuance of common stock upon exercise of stock options	25,073					25,073
Stock-based compensation expense	329,723					329,723
Vesting of restricted stock units (in shares)					13,916
Vesting of restricted stock units			$ 0		$ 1			$ (1)
Tax withholding on vesting of equity awards (in shares)				(643)
Tax withholding on vesting of equity awards	(19,601)					(19,601)
Common stock issued under employee stock purchase plan (in shares)				3,014
Common stock issued under employee stock purchase plan	39,965					39,965
Repurchase of common stock (in shares)				(7,832)
Repurchases of common stock	(219,068)					(219,068)
Other comprehensive income (loss)	(7,139)								(7,139)
Net income	73,071									73,071
Ending balance (in shares) at Feb. 05, 2023				304,076
Ending balance at Feb. 05, 2023	941,233			$ 30		2,493,769			(15,504)	(1,537,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				4,770
Issuance of common stock upon exercise of stock options	39,734					39,734
Stock-based compensation expense	337,146					337,146
Vesting of restricted stock units (in shares)					14,038
Vesting of restricted stock units			0		$ 2			(2)
Tax withholding on vesting of equity awards (in shares)				(909)
Tax withholding on vesting of equity awards	(29,984)					(29,984)
Common stock issued under employee stock purchase plan (in shares)				2,233
Common stock issued under employee stock purchase plan	45,089					45,089
Repurchase of common stock (in shares)				(4,686)
Repurchases of common stock	(135,801)					(135,801)
Issuance of common stock upon conversion of convertible senior notes (in shares)				1
Issuance of common stock upon conversion of convertible senior notes	(356)					(356)
Other comprehensive income (loss)	11,722								11,722
Net income	61,311									61,311
Ending balance (in shares) at Feb. 04, 2024				319,523
Ending balance at Feb. 04, 2024	1,270,094			$ 32		2,749,595			(3,782)	(1,475,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,067
Issuance of common stock upon exercise of stock options	26,905					26,905
Stock-based compensation expense	429,075					429,075
Vesting of restricted stock units (in shares)					12,370
Vesting of restricted stock units			$ 0		$ 1			$ (1)
Tax withholding on vesting of equity awards (in shares)				(3,518)
Tax withholding on vesting of equity awards	(208,833)					(208,833)
Common stock issued under employee stock purchase plan (in shares)				2,388
Common stock issued under employee stock purchase plan	51,736					51,736
Repurchase of common stock (in shares)				(6,728)
Repurchases of common stock	(373,977)					(373,977)
Other comprehensive income (loss)	4,736								4,736
Net income	106,739									106,739
Ending balance (in shares) at Feb. 02, 2025				326,102
Ending balance at Feb. 02, 2025	$ 1,306,475			$ 33		$ 2,674,500			$ 954	$ (1,369,012)